# Beacon Biosignals Raises Oversubscribed $86M Series B for AI Brain Health Platform

> financing · REPORTED · 2025-11-13

Boston-based neurotechnology company Beacon Biosignals closed an oversubscribed $86 million Series B round in November 2025 to scale its Waveband EEG headband device and AI brain health platform. Investors included Google Ventures, Innoviva, Takeda, and General Catalyst, with the company's platform having received FDA clearance in September 2023.

About Beacon Biosignals: Beacon Biosignals develops wearable EEG brain monitoring technology and AI-driven biomarker analysis to generate objective measures of brain function during sleep and wakefulness, serving clinical research and drug development.

- Company: Beacon Biosignals
- Sector: neurotech
- Primary source: https://www.arnoldporter.com/en/perspectives/publications/2025/11/virtual-and-digital-health-digest

---
Source: MedFuel Intel news monitor. Verification tier: REPORTED. Informational only, not investment advice. Corrections: media@medfuelinc.com.